{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Cross T"],"funding":["Breast Cancer Research Foundation","Susan G. Komen","New York State Department of Health - Wadsworth Center","U.S. Department of Defense","National Cancer Institute","NCI NIH HHS","Roswell Park Alliance Foundation, Roswell Park Cancer Institute"],"pagination":["2126-2135"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9729381"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["31(12)"],"pubmed_abstract":["Background
Recent evidence suggests that vitamin D might lower breast cancer mortality. There is also growing interest in vitamin D's potential association with health-related quality-of-life (HRQoL). Associations between circulating 25-hydroxyvitamin D (25OHD) concentrations and HRQoL were examined prospectively among breast cancer survivors at the time of diagnosis and 1 year later.Methods
504 women with incident early-stage breast cancer at Roswell Park Comprehensive Cancer Center were included, and 372 patients provided assessments 1 year later. At each timepoint, participants provided blood samples and completed the SF-36 Health Survey, and surveys on perceived stress, depression, and fatigue. Season-adjusted serum 25OHD concentrations were analyzed in relation to HRQo"],"journal":["Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"],"pubmed_title":["Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study."],"pmcid":["PMC9729381"],"funding_grant_id":["P30CA016056","P30 CA016056","C020918","DoD W81XWH0610401","BCTR104906"],"pubmed_authors":["O'Connor TL","Barone N","Attwood K","Zhang Y","Cross T","Hong CC","George A","Yao S","Hulme K","Ambrosone CB"],"additional_accession":[]},"is_claimable":false,"name":"Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study.","description":"Background
Recent evidence suggests that vitamin D might lower breast cancer mortality. There is also growing interest in vitamin D's potential association with health-related quality-of-life (HRQoL). Associations between circulating 25-hydroxyvitamin D (25OHD) concentrations and HRQoL were examined prospectively among breast cancer survivors at the time of diagnosis and 1 year later.Methods
504 women with incident early-stage breast cancer at Roswell Park Comprehensive Cancer Center were included, and 372 patients provided assessments 1 year later. At each timepoint, participants provided blood samples and completed the SF-36 Health Survey, and surveys on perceived stress, depression, and fatigue. Season-adjusted serum 25OHD concentrations were analyzed in relation to HRQo","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-26T22:57:44.684Z","creation":"2025-04-06T17:23:28.442Z"},"accession":"S-EPMC9729381","cross_references":{"pubmed":["36126952"],"doi":["10.1158/1055-9965.EPI-22-0343","10.1158/1055-9965.epi-22-0343"]}}